Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2017 Filed Jul 5, 2017 23:45 UTC |
Desroches PascalDirector
|
GrantCommon Stock | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-17-000044 · wf-form4_149929834540459.xml · nonDerivative · entry 1 Desroches Pascal · CIK 0001423061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 23:45 UTC |
YALE PHYLLIS RDirector
|
GrantCommon Stock | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-17-000043 · wf-form4_149929832165709.xml · nonDerivative · entry 1 YALE PHYLLIS R · CIK 0001269070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,406 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 23:45 UTC |
DIAZ PAUL JDirector
|
GrantCommon Stock | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-17-000042 · wf-form4_149929830525020.xml · nonDerivative · entry 1 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,432 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 23:44 UTC |
Arway Pamela MDirector
|
GrantCommon Stock | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-17-000041 · wf-form4_149929828602427.xml · nonDerivative · entry 1 Arway Pamela M · CIK 0001464822 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,146 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 23:44 UTC |
NEHRA JOHN MDirector
|
GrantCommon Stock | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-17-000040 · wf-form4_149929826854887.xml · nonDerivative · entry 1 NEHRA JOHN M · CIK 0001005547 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 23:44 UTC |
GRAUER PETER TDirector
|
GrantCommon Stock | 536 | $0.00 | $0.00 |
DisclosureSEC source: 0000927066-17-000039 · wf-form4_149929824653314.xml · nonDerivative · entry 1 GRAUER PETER T · CIK 0001065603 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,296 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 22:31 UTC |
Desroches PascalDirector
|
GrantStock Appreciation Rights · Derivative | 7,178 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000927066-17-000022 · wf-form4_149799789064718.xml · derivative · entry 2 Desroches Pascal · CIK 0001423061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,178 Underlying: Common Stock · 7,178 shares Expires 2022-06-16 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 22:31 UTC |
DAVIDSON CAROL ANTHONYDirector
|
GrantStock Appreciation Rights · Derivative | 7,178 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000927066-17-000021 · wf-form4_149799787023023.xml · derivative · entry 2 DAVIDSON CAROL ANTHONY · CIK 0001277489 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,178 Underlying: Common Stock · 7,178 shares Expires 2022-06-16 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 22:31 UTC |
GRAUER PETER TDirector
|
GrantStock Appreciation Rights · Derivative | 10,484 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000927066-17-000020 · wf-form4_149799785123594.xml · derivative · entry 2 GRAUER PETER T · CIK 0001065603 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,484 Underlying: Common Stock · 10,484 shares Expires 2022-06-16 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 22:30 UTC |
YALE PHYLLIS RDirector
|
GrantStock Appreciation Rights · Derivative | 7,178 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000927066-17-000019 · wf-form4_149799783040127.xml · derivative · entry 2 YALE PHYLLIS R · CIK 0001269070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,178 Underlying: Common Stock · 7,178 shares Expires 2022-06-16 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 22:30 UTC |
ROPER WILLIAM LDirector
|
GrantStock Appreciation Rights · Derivative | 7,178 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000927066-17-000018 · wf-form4_149799780957392.xml · derivative · entry 2 ROPER WILLIAM L · CIK 0001087960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,178 Underlying: Common Stock · 7,178 shares Expires 2022-06-16 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 22:30 UTC |
Arway Pamela MDirector
|
GrantStock Appreciation Rights · Derivative | 7,178 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000927066-17-000017 · wf-form4_149799779140398.xml · derivative · entry 2 Arway Pamela M · CIK 0001464822 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,178 Underlying: Common Stock · 7,178 shares Expires 2022-06-16 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 22:29 UTC |
NEHRA JOHN MDirector
|
GrantStock Appreciation Rights · Derivative | 7,178 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000927066-17-000016 · wf-form4_149799777012768.xml · derivative · entry 2 NEHRA JOHN M · CIK 0001005547 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,178 Underlying: Common Stock · 7,178 shares Expires 2022-06-16 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 22:29 UTC |
DIAZ PAUL JDirector
|
GrantStock Appreciation Rights · Derivative | 7,178 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000927066-17-000015 · wf-form4_149799775311735.xml · derivative · entry 2 DIAZ PAUL J · CIK 0001194247 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,178 Underlying: Common Stock · 7,178 shares Expires 2022-06-16 Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 22:29 UTC |
DESOER BARBARA JDirector
|
GrantStock Appreciation Rights · Derivative | 7,178 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000927066-17-000014 · wf-form4_149799772801190.xml · derivative · entry 2 DESOER BARBARA J · CIK 0001189881 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,178 Underlying: Common Stock · 7,178 shares Expires 2022-06-16 Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 21:59 UTC |
JIGANTI JEANINE MARIEChief Compliance Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 5,200 | $58.94 Strike: $58.94 | $306,488.00 |
DisclosureSEC source: 0000927066-17-000003 · wf-form4_149756397456297.xml · derivative · entry 6 JIGANTI JEANINE MARIE · CIK 0001566865 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,200 shares Expires 2019-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Stock Appreciation Rights were granted on 3/19/2013. 50% vested on 3/19/2016 and the remaining 50% vested on 3/19/2017. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 21:59 UTC |
JIGANTI JEANINE MARIEChief Compliance Officer
|
Exercise / conversionStock Appreciation Rights · Derivative | 7,500 | $53.16 Strike: $53.16 | $398,700.00 |
DisclosureSEC source: 0000927066-17-000003 · wf-form4_149756397456297.xml · derivative · entry 5 JIGANTI JEANINE MARIE · CIK 0001566865 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2017-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Stock Appreciation Rights were granted on 12/05/2012. 50% vested on 12/05/2015 and the remaining 50% vested on 12/05/2016. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 21:59 UTC |
JIGANTI JEANINE MARIEChief Compliance Officer
|
SaleCommon Stock | 1,886 | $65.57 | $123,664.64 |
DisclosureSEC source: 0000927066-17-000003 · wf-form4_149756397456297.xml · nonDerivative · entry 4 JIGANTI JEANINE MARIE · CIK 0001566865 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,514 F1 · price: Represents the weighted average sale price of $65.5698. The range of prices for the sale of these shares was $65.5500-$65.5900, rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 21:59 UTC |
JIGANTI JEANINE MARIEChief Compliance Officer
|
Tax withholdingCommon Stock | 10,814 | $65.22 | $705,289.08 |
DisclosureSEC source: 0000927066-17-000003 · wf-form4_149756397456297.xml · nonDerivative · entry 3 JIGANTI JEANINE MARIE · CIK 0001566865 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,400 Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 21:59 UTC |
JIGANTI JEANINE MARIEChief Compliance Officer
|
Exercise / conversionCommon Stock | 5,200 | $58.94 | $306,488.00 |
DisclosureSEC source: 0000927066-17-000003 · wf-form4_149756397456297.xml · nonDerivative · entry 2 JIGANTI JEANINE MARIE · CIK 0001566865 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 21:59 UTC |
JIGANTI JEANINE MARIEChief Compliance Officer
|
Exercise / conversionCommon Stock | 7,500 | $53.16 | $398,700.00 |
DisclosureSEC source: 0000927066-17-000003 · wf-form4_149756397456297.xml · nonDerivative · entry 1 JIGANTI JEANINE MARIE · CIK 0001566865 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 06, 2017 Filed Jun 9, 2017 01:05 UTC |
ZUMWALT LEANNE MGrp VP, Purch & Public Affairs
|
GrantStock Appreciation Rights · Derivative | 20,929 | $0.00 Strike: $65.48 | $0.00 |
DisclosureSEC source: 0001179110-17-008784 · edgar.xml · derivative · entry 2 ZUMWALT LEANNE M · CIK 0001204946 · Grp VP, Purch & Public Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,929 Underlying: Common Stock · 20,929 shares Expires 2022-05-15 F1 · derivative.exercise_date: The Stock Appreciation Rights were granted on 6/6/2017. 50% will vest on 5/15/2020 and the remaining 50% will vest on 5/15/2021. Read SEC document |
| June 06, 2017 Filed Jun 9, 2017 01:04 UTC |
Waters Kathleen AlyceChief Legal Officer
|
GrantStock Appreciation Rights · Derivative | 20,929 | $0.00 Strike: $65.48 | $0.00 |
DisclosureSEC source: 0001179110-17-008783 · edgar.xml · derivative · entry 2 Waters Kathleen Alyce · CIK 0001640409 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,929 Underlying: Common Stock · 20,929 shares Expires 2022-05-15 F1 · derivative.exercise_date: The Stock Appreciation Rights were granted on 6/6/2017. 50% will vest on 5/15/2020 and the remaining 50% will vest on 5/15/2021. Read SEC document |
| June 06, 2017 Filed Jun 9, 2017 01:04 UTC |
THIRY KENT JDirector · Chairman and CEO
|
GrantStock Appreciation Rights · Derivative | 418,570 | $0.00 Strike: $65.48 | $0.00 |
DisclosureSEC source: 0001179110-17-008782 · edgar.xml · derivative · entry 2 THIRY KENT J · CIK 0001097391 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,570 Underlying: Common Stock · 418,570 shares Expires 2022-05-15 F1 · derivative.exercise_date: The Stock Appreciation Rights were granted on 6/6/2017. 50% will vest on 5/15/2020 and the remaining 50% will vest on 5/15/2021. Read SEC document |
| June 06, 2017 Filed Jun 9, 2017 01:04 UTC |
Rodriguez JavierCEO-Kidney Care
|
GrantStock Appreciation Rights · Derivative | 79,909 | $0.00 Strike: $65.48 | $0.00 |
DisclosureSEC source: 0001179110-17-008781 · edgar.xml · derivative · entry 2 Rodriguez Javier · CIK 0001415548 · CEO-Kidney Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,909 Underlying: Common Stock · 79,909 shares Expires 2022-05-15 F1 · derivative.exercise_date: The Stock Appreciation Rights were granted on 6/6/2017. 50% will vest on 5/15/2020 and the remaining 50% will vest on 5/15/2021. Read SEC document |
| June 06, 2017 Filed Jun 9, 2017 01:03 UTC |
HILGER JAMES KChief Accounting Officer
|
GrantCommon Stock | 3,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008780 · edgar.xml · nonDerivative · entry 1 HILGER JAMES K · CIK 0001264734 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,649 F1 · kind: These restricted stock units were granted on 6/6/2017. They are scheduled to vest 50% each on 5/15/2020 and 5/15/2021, subject to continued service through each applicable vesting date. Read SEC document |
| May 16, 2017 Filed May 17, 2017 23:00 UTC |
GRAUER PETER TDirector
|
Exercise / conversionStock Appreciation Rights · Derivative | 36,000 | $42.47 Strike: $42.47 | $1,528,740.00 |
DisclosureSEC source: 0001179110-17-007453 · edgar.xml · derivative · entry 3 GRAUER PETER T · CIK 0001065603 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2017-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Stock Appreciation Rights were granted on 6/11/2012, and vested 100% on 6/11/2013. Read SEC document |
| May 16, 2017 Filed May 17, 2017 23:00 UTC |
GRAUER PETER TDirector
|
Tax withholdingCommon Stock | 23,153 | $66.03 | $1,528,792.59 |
DisclosureSEC source: 0001179110-17-007453 · edgar.xml · nonDerivative · entry 2 GRAUER PETER T · CIK 0001065603 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,760 Read SEC document |
| May 16, 2017 Filed May 17, 2017 23:00 UTC |
GRAUER PETER TDirector
|
Exercise / conversionCommon Stock | 36,000 | $42.47 | $1,528,740.00 |
DisclosureSEC source: 0001179110-17-007453 · edgar.xml · nonDerivative · entry 1 GRAUER PETER T · CIK 0001065603 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:59 UTC |
Rodriguez JavierCEO-Kidney Care
|
SaleCommon Stock | 1,294 | $66.21 | $85,670.31 |
DisclosureSEC source: 0001179110-17-007452 · edgar.xml · nonDerivative · entry 2 Rodriguez Javier · CIK 0001415548 · CEO-Kidney Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,817 F1 · price: Represents the weighted average sale price of $65.2058. The range of prices for the sale of these shares was $66.1300 - $66.2550 rounded to the nearest ten-thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:59 UTC |
Rodriguez JavierCEO-Kidney Care
|
GrantCommon Stock | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007452 · edgar.xml · nonDerivative · entry 1 Rodriguez Javier · CIK 0001415548 · CEO-Kidney Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,111 Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:59 UTC |
THIRY KENT JDirector · Chairman and CEO
|
GrantCommon Stock | 2,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-007451 · edgar.xml · nonDerivative · entry 1 THIRY KENT J · CIK 0001097391 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,306 Read SEC document |
| May 15, 2017 Filed May 17, 2017 21:24 UTC |
ZUMWALT LEANNE MGrp VP, Purch & Public Affairs
|
SaleCommon Stock | 1,800 | $66.32 | $119,377.80 |
DisclosureSEC source: 0001179110-17-007439 · edgar.xml · nonDerivative · entry 1 ZUMWALT LEANNE M · CIK 0001204946 · Grp VP, Purch & Public Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,023 F1 · kind: The Restricted Stock Units were granted on 4/24/2014. 50% vested on 5/15/2017 and the remaining 50% will vest on 5/15/2018. Read SEC document |
| May 15, 2017 Filed May 17, 2017 21:23 UTC |
JIGANTI JEANINE MARIEChief Compliance Officer
|
SaleCommon Stock | 540 | $66.07 | $35,677.85 |
DisclosureSEC source: 0001179110-17-007438 · edgar.xml · nonDerivative · entry 1 JIGANTI JEANINE MARIE · CIK 0001566865 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,514 F1 · kind: The Restricted Stock Units were granted on 4/24/2014. 50% vested on 5/15/2017 and the remaining 50% will vest on 5/15/2018. F2 · balance_after: Includes 214 shares acquired by the Reporting Person under the Issuer's employee stock purchase plan on 12/30/2016. Read SEC document |
| May 15, 2017 Filed May 17, 2017 21:22 UTC |
HILGER JAMES KChief Accounting Officer
|
SaleCommon Stock | 900 | $66.05 | $59,445.09 |
DisclosureSEC source: 0001179110-17-007436 · edgar.xml · nonDerivative · entry 1 HILGER JAMES K · CIK 0001264734 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,605 F1 · kind: The Restricted Stock Units were granted on 4/24/2014. 50% vested on 5/15/2017 and the remaining 50% will vest on 5/15/2018. F2 · balance_after: Includes 358 shares acquired by the Reporting Person under the Issuer's employee stock purchase plan on 12/30/2016. Read SEC document |
| May 09, 2017 Filed May 11, 2017 22:20 UTC |
BERG CHARLESDirector
|
Exercise / conversionStock Appreciation Rights · Derivative | 24,000 | $42.47 Strike: $42.47 | $1,019,160.00 |
DisclosureSEC source: 0001179110-17-007085 · edgar.xml · derivative · entry 5 BERG CHARLES · CIK 0001111804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2017-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Stock Appreciation Rights were granted on 6/11/2012, and vested 100% on 6/11/2013. Read SEC document |
| May 09, 2017 Filed May 11, 2017 22:20 UTC |
BERG CHARLESDirector
|
SaleCommon Stock | 8,414 | $65.80 | $553,606.70 |
DisclosureSEC source: 0001179110-17-007085 · edgar.xml · nonDerivative · entry 3 BERG CHARLES · CIK 0001111804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,719 F1 · price: Represents the weighted average sale price of $65.7959. The range of prices for the sale of these shares was $65.6300 - $65.9100 rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 09, 2017 Filed May 11, 2017 22:20 UTC |
BERG CHARLESDirector
|
Tax withholdingCommon Stock | 15,586 | $65.39 | $1,019,168.54 |
DisclosureSEC source: 0001179110-17-007085 · edgar.xml · nonDerivative · entry 2 BERG CHARLES · CIK 0001111804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,133 Read SEC document |
| May 09, 2017 Filed May 11, 2017 22:20 UTC |
BERG CHARLESDirector
|
Exercise / conversionCommon Stock | 24,000 | $42.47 | $1,019,160.00 |
DisclosureSEC source: 0001179110-17-007085 · edgar.xml · nonDerivative · entry 1 BERG CHARLES · CIK 0001111804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 8, 2017 18:58 UTC |
Valine RogerDirector
|
Exercise / conversionStock Appreciation Rights · Derivative | 36,000 | $42.47 Strike: $42.47 | $1,528,740.00 |
DisclosureSEC source: 0001179110-17-006797 · edgar.xml · derivative · entry 5 Valine Roger · CIK 0001310132 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2017-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Stock Appreciation Rights were granted on 6/11/2012, and vested 100% on 6/11/2013. Read SEC document |
| May 04, 2017 Filed May 8, 2017 18:58 UTC |
Valine RogerDirector
|
SaleCommon Stock | 12,994 | $66.21 | $860,366.52 |
DisclosureSEC source: 0001179110-17-006797 · edgar.xml · nonDerivative · entry 3 Valine Roger · CIK 0001310132 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Represents the weighted average sale price of $66.2126. The range of prices for the sale of these shares was $66.0750 - $66.2950 rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 04, 2017 Filed May 8, 2017 18:58 UTC |
Valine RogerDirector
|
Tax withholdingCommon Stock | 23,006 | $66.45 | $1,528,748.70 |
DisclosureSEC source: 0001179110-17-006797 · edgar.xml · nonDerivative · entry 2 Valine Roger · CIK 0001310132 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,994 Read SEC document |
| May 04, 2017 Filed May 8, 2017 18:58 UTC |
Valine RogerDirector
|
Exercise / conversionCommon Stock | 36,000 | $42.47 | $1,528,740.00 |
DisclosureSEC source: 0001179110-17-006797 · edgar.xml · nonDerivative · entry 1 Valine Roger · CIK 0001310132 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 8, 2017 18:58 UTC |
NEHRA JOHN MDirector
|
Exercise / conversionStock Appreciation Rights · Derivative | 36,000 | $42.47 Strike: $42.47 | $1,528,740.00 |
DisclosureSEC source: 0001179110-17-006796 · edgar.xml · derivative · entry 4 NEHRA JOHN M · CIK 0001005547 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2017-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Stock Appreciation Rights were granted on 6/11/2012, and vested 100% on 6/11/2013. Read SEC document |
| May 04, 2017 Filed May 8, 2017 18:58 UTC |
NEHRA JOHN MDirector
|
Tax withholdingCommon Stock | 23,006 | $66.45 | $1,528,748.70 |
DisclosureSEC source: 0001179110-17-006796 · edgar.xml · nonDerivative · entry 2 NEHRA JOHN M · CIK 0001005547 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,994 Read SEC document |
| May 04, 2017 Filed May 8, 2017 18:58 UTC |
NEHRA JOHN MDirector
|
Exercise / conversionCommon Stock | 36,000 | $42.47 | $1,528,740.00 |
DisclosureSEC source: 0001179110-17-006796 · edgar.xml · nonDerivative · entry 1 NEHRA JOHN M · CIK 0001005547 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 8, 2017 18:55 UTC |
ROPER WILLIAM LDirector
|
Exercise / conversionStock Appreciation Rights · Derivative | 36,000 | $42.47 Strike: $42.47 | $1,528,740.00 |
DisclosureSEC source: 0001179110-17-006795 · edgar.xml · derivative · entry 4 ROPER WILLIAM L · CIK 0001087960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,000 shares Expires 2017-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Stock Appreciation Rights were granted on 6/11/2012, and vested 100% on 6/11/2013. Read SEC document |
| May 04, 2017 Filed May 8, 2017 18:55 UTC |
ROPER WILLIAM LDirector
|
SaleCommon Stock | 12,994 | $65.89 | $856,147.37 |
DisclosureSEC source: 0001179110-17-006795 · edgar.xml · nonDerivative · entry 3 ROPER WILLIAM L · CIK 0001087960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,277 F1 · price: Represents the weighted average sale price of $65.8879. The range of prices for the sale of these shares was $65.6600 - $66.2800 rounded to the nearest thousandths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 04, 2017 Filed May 8, 2017 18:55 UTC |
ROPER WILLIAM LDirector
|
Tax withholdingCommon Stock | 23,006 | $66.45 | $1,528,748.70 |
DisclosureSEC source: 0001179110-17-006795 · edgar.xml · nonDerivative · entry 2 ROPER WILLIAM L · CIK 0001087960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,271 Read SEC document |
| May 04, 2017 Filed May 8, 2017 18:55 UTC |
ROPER WILLIAM LDirector
|
Exercise / conversionCommon Stock | 36,000 | $42.47 | $1,528,740.00 |
DisclosureSEC source: 0001179110-17-006795 · edgar.xml · nonDerivative · entry 1 ROPER WILLIAM L · CIK 0001087960 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.